Endothelin and endothelin receptors in the renal and cardiovascular systems

作者: Nicolas Vignon-Zellweger , Susi Heiden , Takashi Miyauchi , Noriaki Emoto

DOI: 10.1016/J.LFS.2012.03.026

关键词:

摘要: Endothelin-1 (ET-1) is a multifunctional hormone which regulates the physiology of cardiovascular and renal systems. ET-1 modulates cardiac contractility, systemic vascular resistance, salt water reabsorption, glomerular function. responsible for variety cellular events: contraction, proliferation, apoptosis, etc. These effects take place after activation two endothelin receptors ET(A) ET(B), are present - among others on cardiomyocytes, fibroblasts, smooth muscle endothelial cells, tubular cells kidney. The complex numerous intracellular pathways, can be contradictory in term functional response depending receptor type, cell type physiological situation, described this review. Many diseases share an enhanced expression as part pathophysiology. However, use blockers currently restricted to pulmonary arterial hypertension, more recently digital ulcer. complexity system does not facilitate translation molecular knowledge clinical applications. Endothelin antagonists prevent disease development but secondary undesirable limit their usage. Nevertheless, increasing understanding maintains promising therapeutic target.

参考文章(166)
Christopher M O’Connor, Wendy A Gattis, Kirkwood F Adams, Vic Hasselblad, Bleakley Chandler, Aline Frey, Isaac Kobrin, Maurizio Rainisio, Monica R Shah, John Teerlink, Mihai Gheorghiade, RITZ-4 Investigators, None, Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the Randomized Intravenous TeZosentan Study (RITZ-4). Journal of the American College of Cardiology. ,vol. 41, pp. 1452- 1457 ,(2003) , 10.1016/S0735-1097(03)00194-3
Marina Morigi, Simona Buelli, Stefania Angioletti, Cristina Zanchi, Lorena Longaretti, Carla Zoja, Miriam Galbusera, Sara Gastoldi, Peter Mundel, Giuseppe Remuzzi, Ariela Benigni, In Response to Protein Load Podocytes Reorganize Cytoskeleton and Modulate Endothelin-1 Gene : Implication for Permselective Dysfunction of Chronic Nephropathies American Journal of Pathology. ,vol. 166, pp. 1309- 1320 ,(2005) , 10.1016/S0002-9440(10)62350-4
Nelson Ruiz-Opazo, Kenji Hirayama, Kaoru Akimoto, Victoria L. M. Herrera, Molecular characterization of a dual endothelin-1/Angiotensin II receptor. Molecular Medicine. ,vol. 4, pp. 96- 108 ,(1998) , 10.1007/BF03401733
Peter Johnström, Tim D Fryer, Hugh K Richards, Neil G Harris, Olivier Barret, John C Clark, John D Pickard, Anthony P Davenport, Positron emission tomography using 18F‐labelled endothelin‐1 reveals prevention of binding to cardiac receptors owing to tissue‐specific clearance by ETB receptors in vivo British Journal of Pharmacology. ,vol. 144, pp. 115- 122 ,(2005) , 10.1038/SJ.BJP.0706064
H I Magazine, H Ende, H Tsukahara, M S Goligorsky, W F Bahou, Molecular and functional characterization of the non-isopeptide-selective ETB receptor in endothelial cells. Receptor coupling to nitric oxide synthase. Journal of Biological Chemistry. ,vol. 269, pp. 21778- 21785 ,(1994) , 10.1016/S0021-9258(17)31872-0
O.F. Wagner, G Christ, J Wojta, H Vierhapper, S Parzer, P.J. Nowotny, B Schneider, W Waldhäusl, B.R. Binder, Polar secretion of endothelin-1 by cultured endothelial cells. Journal of Biological Chemistry. ,vol. 267, pp. 16066- 16068 ,(1992) , 10.1016/S0021-9258(18)41966-7
Cécile Fligny, Matthias Barton, Pierre-Louis Tharaux, Endothelin and podocyte injury in chronic kidney disease. Contributions To Nephrology. ,vol. 172, pp. 120- 138 ,(2011) , 10.1159/000328692